Dear Shareholders,

The global economic landscape has been significantly influenced by the Covid-19 pandemic and recent geopolitical events, including the ongoing conflicts in Eastern Europe, Middle East and our neighboring countries. These factors have heightened global economic uncertainty. Inflation, exacerbated by supply chain disruptions, has affected economies worldwide, and the central banks responses—through tight monetary and fiscal policies—have further impacted consumer confidence. According to current reports, advanced economies are expected to experience the most pronounced effects of this slowdown, while emerging markets and developing economies may face a less severe impact.

I would like to mention that the presence of TRUPCR? assays has been well-established in over 60 countries across the UK, Europe, the Middle East, APAC, LATAM, and the United States. We have recently expanded into additional countries in Southeast Asia and the Middle East through our channel partners. We are actively working to enhance our global footprint by adding more channel partners in various regions. Despite the increase in molecular diagnostic labs and manufacturers globally post-Covid, we remain well-positioned to navigate the competitive landscape with our robust product range, exemplary customer support, and highly regarded quality.

We are also in the process of registering our products in markets where demand is strong, in accordance with local medical device regulations. This will facilitate easier access and preference in these markets.

The Board of Directors has proposed a dividend of ^3/- per equity share of ^10/- face value, pending shareholder approval at the forthcoming Annual General Meeting.

As we review the past year, I would like to extend my sincere gratitude to our supply and trade partners for their efforts in ensuring the timely availability of our products.

With a clear strategy and a dedicated, skilled team supporting its implementation, we are confident in our ability to sustain this growth trajectory, achieve our future growth objectives, and deliver long-term value to our shareholders.

Finally, I wish to express my heartfelt thanks to all our employees, customers, stakeholders, and associates, and wish them continued success in their endeavors.